ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,298.27
0.02%
Dow Jones
39,874.18
0.01%
US Dollar vs MXN
16.6502
-0.18%
Brent Oil
83.20
-0.01%
Bitcoin
66,031.43
1.21%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Kiniksa Pharmaceuticals Ltd (KNSA)

  7. Kiniksa Pharmaceuticals Ltd (KNSA) Noticias

KNSA

Kiniksa Pharmaceuticals (KNSA)

Kiniksa Pharmaceuticals Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:KNSA
FechaHoraFuenteTítuloSímboloCompañía
07/05/202415:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
23/04/202406:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
16/04/202415:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/04/202406:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Announces Development Indication for AbiprubartNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
05/03/202415:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
01/03/202416:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
28/02/202406:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
28/02/202406:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
21/02/202415:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
14/02/202415:39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
04/01/202406:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Provides Corporate UpdateNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/01/202415:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/11/202315:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
31/10/202306:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
24/10/202315:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
10/08/202315:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
25/07/202306:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
17/07/202307:00GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
08/06/202316:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
07/06/202316:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
06/06/202315:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
04/05/202315:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/05/202306:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
01/05/202315:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
08/03/202313:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/03/202315:26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
28/02/202307:00GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
27/02/202315:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on February 28, 2023NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
03/02/202310:52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
09/01/202307:00GlobeNewswire Inc.Kiniksa Pharmaceuticals Provides Corporate and Portfolio UpdateNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:KNSA

Su Consulta Reciente

SPI
SP500
S&P 500
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
NYSE
JPM
JP Morgan Chase
FX
EURMXN
Euro vs MXN
FX
EURUSD
Euro vs US Dollar
CCOM
US500
US 500
NYSE
VZ
Verizon Communications
NASDAQ
AMZN
Amazon.com
NASDAQ
GOOGL
Alphabet
NYSE
AXP
American Express
NASDAQ
NVDA
NVIDIA
AMEX
XLV
Health Care Select Sector
AMEX
SPY
SPDR S&P 500
AMEX
XLF
Financial Select Sector
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados